Position in GILD
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,028,154
-$75,517 QoQ
Shares Held
8,138
+2.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,052
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KLINGENSTEIN FIELDS & CO LP holds $198,349,712 across 10 Drug Manufacturers - General names. GILD ranks #5 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
91,363 | $109,583,531 | |
| 2 | JNJ |
Johnson & Johnson
|
218,394 | $55,465,523 | |
| 3 | MRK |
Merck & Co., Inc.
|
223,496 | $28,719,236 | |
| 4 | ABBV |
AbbVie Inc.
|
5,534 | $1,392,575 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
8,138 | $1,028,154 | |
| 6 | BIIB |
Biogen Inc.
|
2,731 | $590,059 | |
| 7 | NVS |
Novartis AG
|
3,047 | $477,525 | |
| 8 | NVO |
Novo Nordisk A S
|
9,380 | $449,677 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,028,154 | 8,138 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,103,671 | 7,919 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,084,898 | 8,839 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $981,129 | 8,839 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,002,153 | 9,039 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $1,015,621 | 9,064 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $837,241 | 9,064 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $885,685 | 10,564 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $741,948 | 10,814 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $814,100 | 11,114 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $940,850 | 11,614 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $878,821 | 11,727 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $906,882 | 11,767 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $975,229 | 11,754 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $1,009,080 | 11,754 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $731,273 | 11,854 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $732,695 | 11,854 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $709,476 | 11,934 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $872,917 | 12,022 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $883,043 | 12,642 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $949,235 | 13,785 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $890,924 | 13,785 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $873,492 | 14,993 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $978,118 | 15,479 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $1,201,956 | 15,622 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $1,159,976 | 15,516 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||